<DOC>
	<DOC>NCT00800475</DOC>
	<brief_summary>The purpose of this study is to determine whether two oral formulations of Gemfibrozil Tablets are bioequivalent.</brief_summary>
	<brief_title>Bioequivalence Study Between Two Oral Formulations of Gemfibrozil Tablets</brief_title>
	<detailed_description />
	<mesh_term>Gemfibrozil</mesh_term>
	<criteria>healthy men or women 18 years of age or older weight within +/ 20% for height and body frame willing to participate and sign a copy of the informed consent form recent history of drug or alcohol addiction or abuse pregnant or lactating women history of allergic response to gemfibrozil use of tobacco products evidence of a clinically significant disorder or whose laboratory results were deemed to be clinically significant receipt of any drugs as part of a research study within 28 days prior to study dosing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>bioavailability</keyword>
	<keyword>Gemfibrozil</keyword>
</DOC>